The ESMO Deep Dive: Gynaecological Cancers Webinar – Is Molecular Classification Leading to Individualised Therapy in Endometrial Cancer?, organized by the European Society for Medical Oncology (ESMO), will take place online on December 2, 2026, at 18:30 CET, bringing together oncology professionals to discuss advances in personalized treatment strategies for endometrial cancer.

The educational session will explore how molecular classification is reshaping the clinical management of endometrial cancer, including its implications for risk stratification, treatment selection, and adjuvant therapy. Particular attention will be given to the FIGO 2023 staging system and the integration of molecular characteristics into clinical decision-making.

The webinar will also examine the evolving role of immunotherapy in advanced and recurrent endometrial cancer, highlighting emerging evidence, remaining therapeutic challenges, and unmet clinical needs. Through expert-led discussion, participants will explore how scientific developments may contribute to more individualized and evidence-based cancer care.